Beyond Air (XAIR) Cash from Financing Activities (2016 - 2026)
Beyond Air (XAIR) posted Cash from Financing Activities of $4.9 million for Q1 2026, up 2350.5% sequentially from $200000.0 in Q4 2025, and up 8.91% YoY from $4.5 million in Q1 2025.
Beyond Air (XAIR) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Beyond Air has reported Cash from Financing Activities for 11 years, with the latest figure at $4.9 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 8.91% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (up 8.64% YoY) and the FY2026 annual result came in at $29.1 million, up 74.76% from the prior year.
- Cash from Financing Activities climbed to $4.9 million in Q1 2026 per XAIR's latest filing, from $200000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $21.6 million in Q3 2024 and troughed at -$9.2 million in Q4 2024.
- A 5-year average of $5.1 million and a median of $4.1 million in 2025 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 4510.66% in 2024, down 275.91% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$310000.0 in 2022, then soared by 1789.68% to $5.2 million in 2023, then slumped by 275.91% to -$9.2 million in 2024, then surged by 102.17% to $200000.0 in 2025, then jumped by 2350.5% to $4.9 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $4.9 million, $200000.0, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Beyond Air | 3.61 Mn | -7.30 Mn | 225,000.00 | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06 Mn |
| Jun 30, 2026 | 3.06 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 8.92 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Jun 30, 2024 | -264,000.00 |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.89 Mn |